SMEs in the BFSI sector are increasingly adopting big data analytics, with 37% as early adopters, driven by regulatory compliance and the need for secure data management. Cloud technologies enhance risk management and operational agility, with 42% prioritizing cloud investments for cost efficiency. In healthcare, challenges like data silos and network connectivity hinder AI and big data adoption, affecting 45% of SMEs. Solutions include integrated data management and cloud-based systems, while a skills gap in cloud professionals can be addressed through training and partnerships.
UBS has maintained a "Sell" rating for Beiersdorf, setting a price target of 111 euros following the company's quarterly results, which showed organic growth falling short of expectations. Analyst Guillaume Delmas noted that despite this, Beiersdorf's outlook for the full year remains optimistic.
11:14 24.10.2024
The Unified Payments Interface (UPI) has revolutionized India's digital payment landscape, increasing digital transactions ninefold since its launch in 2016. Its share in digital transactions surged from 4.4% in FY18 to 70% in FY24, positioning India ahead of its BRICS counterparts in transaction volumes. Prime Minister Modi's advocacy for UPI among BRICS nations highlights its potential to facilitate a cashless economy, with India recently partnering with the UAE for UPI transactions.
Dr Lal PathLabs reported a 9.8% YoY revenue growth in Q2FY25, falling short of expectations, but surprised with an EBITDA margin of 30.7%. The growth was driven by the Swasthfit bundled test package, which increased by 25% YoY. Management plans to focus on volume growth without immediate price hikes, while a cash balance of INR 10bn may be used for M&A to enhance its presence in southern India and other rapidly growing cities. The target price is revised to INR 3,100.
High-net-worth individuals (HNWIs) continue to invest in art and antiques, with median spending stabilizing at $50,000 in 2023 and $25,555 in the first half of 2024. The share of works by female artists reached 44%, and 52% of expenditures were on new and emerging artists. Optimism about the global art market rose, with 91% of HNWIs expecting positive performance in the next six months.
11:08 24.10.2024
AU Small Finance Bank reported a mixed Q2FY25 performance, maintaining a profitability with a RoA of 1.6% and a 6% QoQ loan growth. However, credit costs rose to 1.6%, exceeding guidance due to increased stress in secured retail assets and higher slippages in MFI and credit card segments. The bank has revised its FY25 credit cost guidance to 1.3% and is implementing measures to mitigate slippages, while maintaining a HOLD rating with a target price of INR 630.
Drugs like Ozempic are revolutionizing treatment beyond obesity and diabetes, now showing promise for cardiovascular and kidney diseases, as well as being tested for Alzheimer’s and addiction. As these GLP-1 receptor agonists become more accessible, they could significantly enhance the lives of over a billion people, impacting industries and society at large.
Cipla is set to announce its Q2 earnings on October 29, with expectations of a modest 5% growth in net profit to Rs 1,215 crore, attributed to a lack of major US drug launches and a high comparison base. Revenue is also projected to rise 5% to Rs 6,996 crore, while the EBITDA margin is anticipated to slightly improve to 26%. Analyst forecasts show a tight range, with predictions varying from an 18% increase to a nearly 2% decline in net profit.
In a keynote at the Secure Open Source Software Fusion Conference, Bruce Schneier emphasized the need for "public AI" models that prioritize societal benefits over corporate interests. He expressed cautious optimism about AI's potential to enhance democratic engagement and legislative access, while warning of the unique mistakes AI can make compared to humans. As AI technology evolves, he stressed the importance of thoughtful design and regulatory frameworks to mitigate risks and improve decision-making processes.
SRF's chemicals division is grappling with challenges such as intensified Chinese competition, weak agrochemical demand, delays in new product launches, and declining prices in specialty chemicals and HFCs. Despite these issues, the company anticipates revenue growth in H2FY25, supported by a strong order book and improved margins due to technology advancements and increased volumes. ICICI Securities has downgraded SRF to a HOLD rating, reducing the target price to INR 2,250 from INR 2,480, reflecting a slower recovery in the chemicals sector.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings